DBV Technologies SA

DBV Technologies to Participate in Upcoming EAACI 2024 Congress

30 май 2024 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies Announces Plan to Implement ADS Ratio Change

17 май 2024 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies Announces Results of its 2024 Combined General Meeting

16 май 2024 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming Investor Conferences

09 май 2024 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

07 май 2024 13:30:00 Источник Nasdaq GlobeNewswire

Combined General Meeting of May 16, 2024

25 апр 2024 13:30:00 Источник Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

04 апр 2024 13:43:40 Источник Nasdaq GlobeNewswire

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document

08 мар 2024 06:33:25 Источник Nasdaq GlobeNewswire

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

07 мар 2024 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024

04 мар 2024 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2024 Congress

20 фев 2024 13:30:00 Источник Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

16 янв 2024 13:30:00 Источник Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  

04 дек 2023 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

09 ноя 2023 13:30:00 Источник Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

06 ноя 2023 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies to Present New Data at ACAAI 2023

02 ноя 2023 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results

31 окт 2023 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

27 окт 2023 13:30:00 Источник Nasdaq GlobeNewswire

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer

15 окт 2023 23:00:00 Источник Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

05 окт 2023 13:30:00 Источник Nasdaq GlobeNewswire